Mosaic (MOS) official guidance

Mosaic (MOS) official earnings guidance and management outlook. Each figure management stated is shown with its revisions and the source quote.

See the full Filings Intelligence suite
MOSMOSAIC COQ3 FY2026 · ends 2026-09-30
1 metric1 new
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTC$610 – $620new
Therefore, for the third quarter, we expect realized sulfur costs of approximately $700-$710 per ton and ammonia costs of approximately $610-$620 per ton.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
MOSMOSAIC COFY2026 · ends 2026-12-31
1 metric1 maintained
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTC$1.2Bmaintained-11.7% vs FY2025
Combined with our lower CapEx expectation for the year of $1.2 billion, down from $1.25 billion, we expect sequential improvements in free cash flow in the third and in the fourth quarters.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-04 20:28:02 UTC$1.2Blowered -4.0%-11.7% vs FY2025
Capital expenditures in 2026 are now expected to be $1.20 billion, down from the previous expectation of $1.25 billion.
MOS · EX-99.1 · Q2 FY2026
2026-08-04 20:26:33 UTCOpen source
2026-05-11 14:45:29 UTC$1.3Blowered -16.7%-8% vs FY2025
After careful review of the project portfolio, Mosaic has adjusted its 2026 capital expenditure guidance to $1.25 billion. Lower spending reflects an optimized project portfolio combined with the deferral of spending on less-time sensitive projects to future periods. Mosaic does not expect any material impact to medium term operating rates as a result of these actions.
MOS · EX-99.1 · Q1 FY2026
2026-05-11 14:44:00 UTCOpen source
2026-02-26 05:01:41 UTC$1.5Bmaintained
We expect CapEx in 2026 to come in around $1.5 billion, higher than 2025, due to mine, gypstack, and clay settling area expansions in Florida.
MOS · transcript · Q4 FY2025
2026-02-26 05:00:00 UTCOpen source
2026-02-24 21:18:07 UTC$1.5Bnew
| Total Capital Expenditures | Approximately $1.5 billion |
MOS · EX-99.1 · Q4 FY2025
2026-02-24 21:16:28 UTCOpen source
MOSMOSAIC COH4 FY2026 · ends 2026-12-31
1 metric
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTCrevert lower
We expect to revert lower in the second half of the year.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-04 20:28:02 UTCexpected to trend lower through the remainder of the yearnew
Unit production costs are expected to trend lower through the remainder of the year as a result of higher Esterhazy production volumes.
MOS · EX-99.1 · Q2 FY2026
2026-08-04 20:26:33 UTCOpen source
MOSMOSAIC COQ3 FY2026 · ends 2026-09-30
5 metrics4 new1 maintained
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTC40%new
We expect around $30 million of sales of Biosciences only in Brazil with a kind of a margin contribution margin of around 40%.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-06 04:01:51 UTC$820 – $840maintained
Combining this with our DAP FOB pricing guidance of $820-$840 per ton yields an implied realized stripping margin well above historical averages, which is a good result.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-04 20:28:02 UTC$820 – $840new
DAP prices are expected to average $820 to $840 per tonne on an FOB basis.
MOS · EX-99.1 · Q2 FY2026
2026-08-04 20:26:33 UTCOpen source
2026-08-06 04:01:51 UTCsequential improvementsnew
Combined with our lower CapEx expectation for the year of $1.2 billion, down from $1.25 billion, we expect sequential improvements in free cash flow in the third and in the fourth quarters.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-06 04:01:51 UTC$10M – $20Mnew
Let's just put a bracket, $10 million-$20 million additional from Q3 to Q2.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-06 04:01:51 UTCrise furthernew
Mosaic's cash flow from operations improved through the first half of the year, and it is expected to rise further in the third quarter as working capital is released, mostly in Brazil, and as additional cost reductions are realized.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
MOSMOSAIC COH4 FY2026 · ends 2026-12-31
1 metric1 new
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTCdecline furthernew
In the second half of the year, we expect SG&A to decline further as more of these savings are realized.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
MOSMOSAIC COQ3 FY2026 · ends 2026-09-30
1 metric1 new
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTC$30Mnew
In Q3, actually, we're going to start having some contribution from Biosciences in Brazil. We expect around $30 million of sales of Biosciences only in Brazil with a kind of a margin contribution margin of around 40%.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
MOSMOSAIC COFY2026 · ends 2026-12-31
1 metric
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTCdouble its revenues once again this year
Our Mosaic Biosciences business is on track to double its revenues once again this year.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-04 20:28:02 UTCdouble from 2025’s total of $68 million
Net sales in 2026 are expected to double from 2025’s total of $68 million.
MOS · EX-99.1 · Q2 FY2026
2026-08-04 20:26:33 UTCOpen source
2026-05-12 04:01:39 UTCdouble again
We expect Mosaic Biosciences revenues to double again in 2026.
MOS · transcript · Q1 FY2026
2026-05-12 04:00:00 UTCOpen source
2026-05-11 14:45:29 UTCdouble 2025 net sales
Mosaic Biosciences is expected to launch 8-10 new products(3) in 2026, inclusive of two products launched in the first quarter. Revenues in 2026 are expected to double 2025 net sales of $68 million.
MOS · EX-99.1 · Q1 FY2026
2026-05-11 14:44:00 UTCOpen source
2026-02-26 05:01:41 UTCanother year of doubling net sales
Looking ahead to 2026, our expectation of continued adoption across our current portfolio, along with 8-10 anticipated new product launches, positions us to achieve another year of doubling net sales.
MOS · transcript · Q4 FY2025
2026-02-26 05:00:00 UTCOpen source
2026-02-24 21:18:07 UTCto approximately double compared with 2025new
In 2026, Mosaic Biosciences expects to launch eight to ten new products and targets net sales to approximately double compared with 2025.
MOS · EX-99.1 · Q4 FY2025
2026-02-24 21:16:28 UTCOpen source
MOSMOSAIC COQ3 FY2026 · ends 2026-09-30
3 metrics3 new
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTC600K – 800Knew
Historically, we see Q3 over Q2 roughly about 600,000 tons-800,000 tons more quarter-over-quarter. Would expect the same this year.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-06 04:01:51 UTCwell above historical averagesnew
Combining this with our DAP FOB pricing guidance of $820-$840 per ton yields an implied realized stripping margin well above historical averages, which is a good result.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-06 04:01:51 UTC$700 – $710new
Therefore, for the third quarter, we expect realized sulfur costs of approximately $700-$710 per ton and ammonia costs of approximately $610-$620 per ton.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
MOSMOSAIC COFY2026 · ends 2026-12-31
1 metric1 maintained
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTC$300M – $500Mmaintained
I would say we still subscribe to the $300 million-$500 million release.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-05-12 04:01:39 UTC$300M – $500Mmaintained
We have been saying that $300 million-$500 million release of working capital.
MOS · transcript · Q1 FY2026
2026-05-12 04:00:00 UTCOpen source
2026-02-26 05:01:41 UTC$300M – $500Mnew
In addition, movements in sulfur and ammonia could provide some relief, taken together, we believe a $300 million-$500 million working capital release is highly possible, supporting meaningfully higher cash flow generation in 2026.
MOS · transcript · Q4 FY2025
2026-02-26 05:00:00 UTCOpen source
MOSMOSAIC COQ3 FY2026 · ends 2026-09-30
1 metric1 new
earnings call · 2026-08-06 04:01:51 UTC
2026-08-06 04:01:51 UTC$100M – $200Mnew
We should expect first some release of working capital in Q3, maybe between $100 million and $200 million, but the bulk of the $300 million-$500 million will come in the fourth quarter when the collections come in.
MOS · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
MOSMOSAIC COFY2026 · ends 2026-12-31
1 metric1 lowered
earnings release · 2026-08-04 20:28:02 UTC
2026-08-04 20:28:02 UTC$250M – $300Mlowered -8.3%
| Cash Tax - millions $ | $250 - $300 |
MOS · EX-99.1 · Q2 FY2026
2026-08-04 20:26:33 UTCOpen source
2026-05-11 14:45:29 UTC$275M – $325Mnew
| Cash Tax - millions $ | $275 - $325 |
MOS · EX-99.1 · Q1 FY2026
2026-05-11 14:44:00 UTCOpen source
MOSMOSAIC COQ3 FY2026 · ends 2026-09-30
1 metric1 new
earnings release · 2026-08-04 20:28:02 UTC
2026-08-04 20:28:02 UTCexpected to be below the second quarter resultnew
Challenging producer economics and the full-quarter impact of production curtailments are expected to have a negative impact on the third quarter financial performance. As a result, segment adjusted EBITDA in the third quarter is expected to be below the second quarter result.
MOS · EX-99.1 · Q2 FY2026
2026-08-04 20:26:33 UTCOpen source
MOSMOSAIC COH4 FY2026 · ends 2026-12-31
1 metric1 new
earnings release · 2026-08-04 20:28:02 UTC
2026-08-04 20:28:02 UTCexpected to improve through the remainder of the yearnew
Free cash flow is expected to improve through the remainder of the year as a result of lower capital expenditures and an expected release of working capital, primarily in Brazil.
MOS · EX-99.1 · Q2 FY2026
2026-08-04 20:26:33 UTCOpen source
MOSMOSAIC COFY2026 · ends 2026-12-31
1 metric1 raised
earnings release · 2026-08-04 20:28:02 UTC
2026-08-04 20:28:02 UTC$220M – $240Mraised +9.5%
| Net Interest Expense - millions $ | $220 - $240 |
MOS · EX-99.1 · Q2 FY2026
2026-08-04 20:26:33 UTCOpen source
2026-05-11 14:45:29 UTC$200M – $220Mmaintained
| Net Interest Expense - millions $ | $200 - $220 |
MOS · EX-99.1 · Q1 FY2026
2026-05-11 14:44:00 UTCOpen source
2026-02-24 21:18:07 UTC$200M – $220Mnew
| Net Interest Expense | $200 - $220 million |
MOS · EX-99.1 · Q4 FY2025
2026-02-24 21:16:28 UTCOpen source